Kristine Peterson
Director · ArriVent BioPharma, Inc.
Individual
- 2026
- Jun 23, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kristine Peterson files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- HILLHOUSE INVESTMENT MANAGEMENT, LTD. - $12.98M in AVBP purchases and sales in the last 12 months
- David M. Berman - $3.92M in IMCR purchases and sales in the last 12 months
- Bahija Jallal - $371K in IMCR purchases and sales in the last 12 months
- Jay R. Luly - $67K in ENTA purchases and sales in the last 12 months
- Yat Sun Or - $34K in ENTA purchases and sales in the last 12 months
- Leger Tina Amber St - $32K in IMCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kristine Peterson?
Kristine Peterson is a corporate insider, tracked as Director of ArriVent BioPharma, Inc. (AVBP). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Kristine Peterson last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 3 filings going back to 2026.
